Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.4100 (0.74%) ($5.4100 - $5.4100) on Mon. Jun. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.56% (three month average) | RSI | 84 | Latest Price | $5.4100(0.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XLC(44%) SKYY(42%) XLU(40%) SPLV(30%) XLP(21%) | Factors Impacting CAPR price | CAPR will decline at least -2.28% in a week (0% probabilities). IFRA(-18%) IYT(-9%) JETS(4%) IWD(5%) IWN(24%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.28% (StdDev 4.56%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.95(9.29%) | 10 Day Moving Average | $4.74(14.14%) | 20 Day Moving Average | $4.31(25.52%) | To recent high | 0% | To recent low | 7.6% | Market Cap | $107m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |